Dr. Pfleger Arzneimittel GmbH

Qualitis Ltd, is a Full-Service Clinical Research and Medical Consulting Organization based in Greece and offering a comprehensive portfolio of clinical development and medical consulting services to the Pharmaceutical, Biotechnology and Medical Device industries.

Through a commitment to a Company culture of superior quality service, integrity and innovation, Qualitis focuses on exceeding its customers particular needs and expectations.

Qualitis Team possesses an in-depth and long-term experience and expertise in both clinical research and medical-marketing environment and is strongly dedicated in constant learning and continuous improvement driven to create added value for our customers and become an integral part of their business success.

With a strong focus on people and standards, Qualitis has built upon the 3 milestones of business success: Quality, Commitment and Customer Trust.

Our specialty areas include but are not limited to the following:
-Cardiovascular diseases
-Neurology & Psychiatry
-Pulmonary/Respiratory
-Genitourinary
-Gastroenterology
-Oncology
-Orthopedics
-Pediatrics
-Biotechnology
-Allergy/Immunology
-Dermatology
-Virology
-Endocrinology
-Hematology
-Ophthalmology

Areas of Operation-Projects Portfolio:
-Phase II-IV Clinical Trials
-Medical Device Studies
-Non-Interventional Studies
-Pharmacovigilance Studies
-IIS (Investigator Initiated Studies)
-Epidemiological Studies
-Market Surveys

Customers Profile:
-Pharmaceutical Companies
-Biotechnology Companies
-Medical Devices Companies
-Academic Research Institutes & Hospitals
-International CROs

Contact Details: E-mail: info@qualitis.gr
Telephone: +30 210-7797750
Fax: +30 210-7470441

Covalab is a French biotechnology company specialized in antibody engineering, founded in 1995.

We are expert in the design and development of antibody (polyclonal, monoclonal scFv, FAb, VHH, recombinant antibodies) using antigen or DNA immunization. In addition, we offer purified and labeling antibodies, peptide synthesis for research use, diagnostic and therapeuthic. As a producer, we supply many distributors to sale our innovative and high quality antibodies. Wide range of those products are available in our website.

The service activity of CovalAb represents the top of the scientific and technical iceberg which the team at CovalAb has put together. Indeed, the scientists at CovalAb have more than 30 years of experience in the chemical modification of antigens and antibodies destined for diagnosis and therapy.

A list, by no means complete of some of their achievements:
- In biomedicine, includes the production of: antibodies directed against new tumour markers, antibodies as gene vectors in cancerology, antibodies reacting specifically with cerebral protein aggregates in neurology, diagnostic kits for detecting patients with autoimmune disease such as rheumatoid arthritis and celiac disease.
- In agro-food, the development of complete diagnostic kits including the antibodies and the chemically modified immunogens for the detection of mycotoxins, phycotoxins, pesticides and polyaromatic hydrocarbons.

Our mission is to give to researchers every day high quality antibodies and powerful tools to accelerate your research and move on to discovery. We help our clients to face new challenges in biology and to improve life thanks to translational research, personalized medicine, stem cell therapy and food safety.

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide.

We have offices across 24 countries in Europe and North America, we export to over 50 countries worldwide and have six manufacturing sites. The Dechra Group employ over one thousand people and our revenue in 2018 reached £407.1m.

Our six Dechra Values: Dedication, Enjoyment, Courage, Honesty, Relationships and Ambition reflect the best aspects of behaviour and competence in Dechra. We embrace the values at every level of the business and everything about the business is underpinned by our values. How we talk to the people that matter, the way we always look to do things better and how we think of the people and the animals beyond the product.

We are active in Companion Animal, Equine and Food Producing Animal products.

Our key focus therapeutic areas are:
• Endocrinology
• Dermatology
• Anaesthesia and Analgesia
• Water Medication
• Diets and Nutrition
• Equine Locomotion

And we support our clients in practice with a wide range of materials and technical advice.

Follow us on Twitter - @Dechra

Within Basel neighbourhood and at the very heart of Europe (the triple border of France, Germany and Switzerland), Firalis is a pioneering biotechnology company, active in discovery, development and qualification of biomarkers (BM).

1) BIOMARKER PRODUCTS
Firalis develops BM-based diagnostic, prognostic and theranostic tools:
● RUO Kits (Research-Use-Only), based on validated innovative biomarkers
● IVD Tools (In Vitro Diagnostic), based on a combination of clinically qualified biomarkers

2) BIOMARKER R&D
● Development of proprietary BMs
- Cardiovascular, Inflammatory, Autoimmune and Neurology
● Drug Safety & Drug Efficacy
● Patient Stratification
● Personalized Medicine

3) BIOMARKER-RELATED CRO SERVICES
BM Discovery for laboratories, biotechs and pharmaceutical industry:
- Proteomics: Soluble biomarker measurements with several immunoassays technologies (ELISA, multiplex and high sensitivity platforms such as Luminex® BioPlex 200™, Meso Scale Discovery®, Singulex Erenna®, Protein Simple Ella™, Olink and Siemens Dimension® EXL™ 200)
- Genomics/Transcriptomics: Targeted sequencing of miRNA and mRNA (HTG EdgeSeq), lncRNA screening via Firalis proprietary platform, Next-Generation Sequencing (NGS) services (RNA-Seq, whole genome and exome sequencing, etc.) and qPCR/microfluidic qPCR (Gene Expression, SNP, CNV, etc.)
- Flow Cytometry: Immunophenotyping of preclinical and clinical samples, monitoring of pharmacodynamics on target cells in response to treatment and biomarker discovery
- Assay development and validation on various platforms, development of critical reagents (antibodies and proteins)
- Biobanking and sample repository services supported by LIMS
- Data analysis using multi-parametric statistics and development of predictive models
- Support of regulatory activities related to biomarker qualification with Health Authorities (FDA/EMA)
- Quality environment (ISO 9001, ISO 13485 (GMP), ISO 17025 (GLP/GCLP))

For more information please visit our website.

Accell Clinical Research is an international full-service Contract Research Organization (CRO) managing Phase I-III clinical trials for 10+ years across Eastern Europe. With local presence, including highly qualified medical staff and legal entities in the region, we successfully recruit patients both in EU and outside EU in post-Soviet countries (CIS). All together we provide guaranteed fast patient recruitment in 20+ countries across the region.

⬇︎ ACCELL'S SERVICES for Phase I-III clinical trials:

• Strategic guidance and trial set-up:
• Feasibility research and site selection
• Study documentation development
• Regulatory support
• Clinical supply import and management
• Selection and management of clinical study vendors
• Project management
• Clinical & medical monitoring
• Data management and biostatistics
• Quality assurance
• Safety management
• TMF/eTMF services
• Functional outsourcing of a clinical team

⬇︎ THERAPEUTIC AREAS
• Oncology
• Cardiovascular
• Immunology
• Gastroenterology
• Neurology
• Endocrinology